Helius Medical Technologies, Inc. Provides Update on FDA’s Review of its Request for De Novo Classification
Helius Medical Technologies Receives Medical Device License Clearance from Health Canada for PoNS Device
medical device investing Helius Medical Technologies Announces Uplisting to Nasdaq and Pricing of Public Offering of Class A Common Stock and Warrants
medical device investing Helius Medical Technologies and US Army Research Laboratory Launch Additional PoNS® Research
medical device investing Helius Medical Technologies Announces Launch of Sixth Site for Pivotal Mild to Moderate Traumatic Brain Injury Clinical Trial
medical device investing Helius Medical Technologies Announces Launch of Fifth Site for Pivotal Mild to Moderate Traumatic Brain Injury Clinical Trial
SAGA Metals Completes Phase 2 of Major Drill Program at the Radar Project in Labrador-Confirms Extensive Oxide Mineralization in All Drill Locations at Trapper North and South Zones & Provides Corporate Update
ReeXploration Announces Field Program Results Confirming Large-Scale Uranium Target at Eureka, Namibia
